北京科信必成医药科技发展有限公司

发布时间: 2017-09-21        来源:

Beijing Cosci-Med Ltd.

        我公司是专注于口服固体药物制剂技术创新和产业化转移服务的国家高新技术企业,被评选为国家技术转移示范机构、北京市科技研发机构,G20工程-高端服务企业。

CoSci is a National High-Tech Company focusing on development of add-on value oral solid dosage forms with better clinical benefits. The company has been awarded “National Demonstration Institution on Tech-Transfer”, “Beijing Technology RnD Institution”, “G20 Project – High-Value Service Enterprise”.

公司开发了一批口服固体药物制剂领域的缓控释制剂品种,为客户提供药物研发服务,已建立13项拥有自主知识产权的共性药物制剂创新技术平台、拥有国内外授权发明专利83项,服务客户60多家,其中45家上市企业。实现了儿童掩味颗粒技术平台、精准给药技术平台等具有国际影响力的重大技术突破、505b(2)新药、孤儿药等产品的研发和成果转化。

The company has developed a series of modified-release oral solid formulations, to serve the client and the national healthcare need. CoSci has established 13 technology platforms regarding sophisticated drug formulation, has was granted 83 national and international patents around its formulation and process capabilities. CoSci has served more than 60 partners around the world. The company has developed world class formulations and technologies such as taste masking pediatric granules, precise dosing drugs. CoSci has also built its own Orphan Drug series in order to help such niche population of our citizens suffering from rare diseases.

公司分别承担了国家“十一五”、“十二五”重大新药创制专项,和“十三五”重大新药创制计划“儿童用药品种及关键技术研发”课题。

The company has taken place in National projects such as “11th five-year plan”, “12th five-year plan” and “13th five-year plan”.

科信必成力争用1-2年时间,打造成为一个具有自主创新能力的服务型上市公司,成为在口服固体药物制剂领域具有国际影响力的创新企业。

CoSci plans to become a world-class innovative organization within the next 2 years, in order to serve the industry and the society with better formulation technologies.

浏览次数: 】【打印】【关闭
 

Copyright © 2016 中国(教育部)留学服务中心招聘会服务系统.